These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7490734)

  • 1. Design and synthesis of conformationally constrained analogues of 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one (Ro 20-1724) as potent inhibitors of cAMP-specific phosphodiesterase.
    Brackeen MF; Cowan DJ; Stafford JA; Schoenen FJ; Veal JM; Domanico PL; Rose D; Strickland AB; Verghese M; Feldman PL
    J Med Chem; 1995 Nov; 38(24):4848-54. PubMed ID: 7490734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
    Rusin LJ; Duell EA; Voorhees JJ
    J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.
    Souness JE; Hassall GA; Parrott DP
    Biochem Pharmacol; 1992 Sep; 44(5):857-66. PubMed ID: 1326964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
    Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
    Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Tofovic SP; Jackson EK
    Eur J Pharmacol; 2003 Mar; 465(1-2):133-9. PubMed ID: 12650842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
    Cottam HB; Shih H; Tehrani LR; Wasson DB; Carson DA
    J Med Chem; 1996 Jan; 39(1):2-9. PubMed ID: 8568809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
    Zhu WH; Majluf-Cruz A; Omburo GA
    Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (Imidazolylphenyl)pyrrol-2-one inhibitors of cardiac cAMP phosphodiesterase.
    Lampe JW; Chou YL; Hanna RG; Di Meo SV; Erhardt PW; Hagedorn AA; Ingebretsen WR; Cantor E
    J Med Chem; 1993 Apr; 36(8):1041-7. PubMed ID: 8386770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quaternary substituted PDE4 inhibitors I: the synthesis and in vitro evaluation of a novel series of oxindoles.
    Hulme C; Poli GB; Huang FC; Souness JE; Djuric SW
    Bioorg Med Chem Lett; 1998 Jan; 8(2):175-8. PubMed ID: 9871649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium.
    Oquist NL; Strada SJ; Artman M
    Pediatr Res; 1992 Mar; 31(3):300-4. PubMed ID: 1313959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
    Manganiello V; Degerman E; Elks M
    Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
    [No Abstract]   [Full Text] [Related]  

  • 15. The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration.
    Knapp CM; Foye MM; Ciraulo DA; Kornetsky C
    Pharmacol Biochem Behav; 1999 Jan; 62(1):151-8. PubMed ID: 9972858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective inhibitor of cAMP-specific phosphodiesterase, Ro 20-1724, has no effect on the quantal release of acetylcholine from the mouse phrenic nerve.
    Chiou LC; Chang CC
    J Pharm Pharmacol; 1988 Feb; 40(2):148-9. PubMed ID: 2897454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells.
    Yoshimura T; Kurita C; Nagao T; Usami E; Nakao T; Watanabe S; Kobayashi J; Yamazaki F; Tanaka H; Nagai H
    Gen Pharmacol; 1997 Oct; 29(4):633-8. PubMed ID: 9352314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and structure-activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitors.
    Raboisson P; Lugnier C; Muller C; Reimund JM; Schultz D; Pinna G; Le Bec A; Basaran H; Desaubry L; Gaudiot F; Seloum M; Bourguignon JJ
    Eur J Med Chem; 2003 Feb; 38(2):199-214. PubMed ID: 12620664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G; Tenenhouse A; Vachon C
    Br J Pharmacol; 1982 Nov; 77(3):405-11. PubMed ID: 6291691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.